Pidotimod

匹多莫德

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePidotimod
Drug Alias NameTimodolic acid匹多替莫Thymodolic acid匹多莫特Polimod +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOtitis MediaPulmonary Disease, Chronic ObstructiveUrinary Tract Infections +[6] 
Global Approved IndicationsUrinary Tract InfectionsRespiratory Tract Infections
Approved Indications in ChinaUrinary Tract InfectionsRespiratory Tract Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSunstone (Tangshan) Pharmaceutical Co LtdShenyang Shuangding Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveUrinary Tract InfectionsBronchitis +[5] 
Inactive IndicationsOtitis Media

Other Information

ATC CodeL03AX05
Related LinksWikipediaDrugBankKEGG